United Therapeutics (UTHR) Tops Q3 EPS by 16c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $231.78 -1.4%
EPS Growth %: +19.1%
Financial Fact:
Diluted (in shares): 46.2M
Today's EPS Names:
MFON, SICP, LBAS, More
EPS Growth %: +19.1%
Financial Fact:
Diluted (in shares): 46.2M
Today's EPS Names:
MFON, SICP, LBAS, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $3.50, $0.16 better than the analyst estimate of $3.34. Revenue for the quarter came in at $408.2 million versus the consensus estimate of $402.35 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Adidas (ADDYY) gains after outlook boost
- Midday movers: Morgan Stanley, UnitedHealth rise; Tesla falls
- J.B. Hunt Transport Services (JBHT) Misses Q1 EPS by 30c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
